We are live on
!
Find out more
DCC
Dow Chemical Company Portfolio holdings
AUM
$239M
1-Year Est. Return
13.16%
This Fund
S&P 500
This Quarter
Est. Return
+5.48%
1 Year Est. Return
+13.16%
3 Year Est. Return
+38.95%
5 Year Est. Return
+38.27%
10 Year Est. Return
+161.42%
AUM
$1.19B
AUM Growth
-$26M
(-2.1%)
Cap. Flow
-$84.7M
Cap. Flow
% of AUM
-7.11%
Top 10 Holdings %
Top 10 Hldgs %
76.02%
Holding
103
New
16
Increased
18
Reduced
23
Closed
10
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$11.4M |
| 2 |
OXFD
Oxford Immunotec Global PLC Ordinary Shares
OXFD
|
+$4.96M |
| 3 |
Procter & Gamble
PG
|
+$4.92M |
| 4 |
GE Aerospace
GE
|
+$4.38M |
| 5 |
General Motors
GM
|
+$3.56M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$45.7M |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
+$38.4M |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$23.3M |
| 4 |
iShares Russell 1000 Growth ETF
IWF
|
+$5.53M |
| 5 |
AGN
Allergan Inc
AGN
|
+$4.28M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.56% |
| 2 | Energy | 3.52% |
| 3 | Healthcare | 3.13% |
| 4 | Consumer Discretionary | 1.45% |
| 5 | Industrials | 1.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Target
TGT
$67.3B
| $985K | 0.08% |
17,000
| – | – |
|
77
Emerson Electric
EMR
$88.9B
| $830K | 0.07% |
12,500
-2,500
| -17% | -$168K |
|
78
CNX Resources
CNX
$5.28B
| $691K | 0.06% |
+18,000
| New | +$660K |
|
79
Colgate-Palmolive
CL
$73.8B
| $682K | 0.06% |
+10,000
| New | +$670K |
|
80
Gilead Sciences
GILD
$168B
| $663K | 0.06% |
8,000
| – | – |
|
81
Amazon
AMZN
$2.99T
| $650K | 0.05% |
+40,000
| New | +$633K |
|
82
Gen Digital
GEN
$16.9B
| $646K | 0.05% |
28,200
| – | – |
|
83
Pfizer
PFE
$145B
| $594K | 0.05% |
21,080
| – | – |
|
|
SPLK
84
DELISTED
Splunk Inc
SPLK
| $553K | 0.05% |
+10,000
| New | +$525K |
|
85
Citigroup
C
$230B
| $518K | 0.04% |
11,000
| – | – |
|
86
Teradyne
TER
$63.1B
| $490K | 0.04% |
25,000
| – | – |
|
87
DNOW Inc
DNOW
$2.63B
| $335K | 0.03% |
+9,250
| New | +$318K |
|
|
TTPH
88
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
| $333K | 0.03% |
+1,235
| New | +$265K |
|
89
Xylem
XYL
$28.5B
| $274K | 0.02% |
+7,000
| New | +$262K |
|
|
MON
90
DELISTED
Monsanto Co
MON
| $249K | 0.02% |
+2,000
| New | +$234K |
|
|
FOLD
91
DELISTED
Amicus Therapeutics
FOLD
| $74K | 0.01% |
22,162
| – | – |
|
92
CALL
Suncor Energy
SU
$76.2B
| $11K | ﹤0.01% |
+20,000
| New | +$779K |
|
|
93
PUT
Suncor Energy
SU
$76.2B
| $7K | ﹤0.01% |
+15,000
| New | +$584K |
|
94
Expedia Group
EXPE
$37.5B
| – | – |
-35,000
| Closed | -$2.54M |
|
95
Goodyear
GT
$2.07B
| – | – |
-82,000
| Closed | -$2.14M |
|
96
Hartford Financial Services
HIG
$38.9B
| – | – |
-30,000
| Closed | -$1.06M |
|
97
Johnson Controls International
JCI
$93.1B
| – | – |
-38,200
| Closed | -$1.89M |
|
98
Revvity
RVTY
$12.4B
| – | – |
-5,100
| Closed | -$230K |
|
|
NUVA
99
DELISTED
NuVasive, Inc.
NUVA
| – | – |
-41,800
| Closed | -$1.61M |
|
|
LLL
100
DELISTED
L3 Technologies, Inc.
LLL
| – | – |
-6,000
| Closed | -$709K |
|
Similar funds
OCERS
P
WWA
MFC
GCA
RCM
LOM
FWP
Dow Chemical Company's Q2 2014 Portfolio in Review
As of Q2 2014, Dow Chemical Company held 103 positions worth $1.19B, down 2.1% from $1.22B the previous quarter. Its ten largest holdings account for 76% of the portfolio.
Dow Chemical Company withdrew a net $84.7M in Q2 2014, closing 10 positions and reducing 23 holdings. Its most notable exit was Allergan Inc, an estimated $4.28M position sold in full.
By sector, the portfolio is most concentrated in Technology at 3.6% of assets, down from 3.6% a quarter earlier, followed by Energy and Healthcare.
Against the trend, Dow Chemical Company opened a new position in Oxford Immunotec Global PLC Ordinary Shares worth $4.64M.
- Dow Chemical Company's largest Q2 2014 buy was Oxford Immunotec Global PLC Ordinary Shares: 275,755 shares worth $4.64M.
- Dow Chemical Company added most to State Street Technology Select Sector SPDR ETF in Q2 2014, an estimated $11.4M increase.
- Dow Chemical Company's biggest Q2 2014 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $45.7M.
- Dow Chemical Company fully exited Allergan Inc in Q2 2014, selling an estimated $4.28M.
- Dow Chemical Company's ten largest holdings make up 76% of its $1.19B portfolio in Q2 2014.
- Dow Chemical Company opened 16 new positions and closed 10 in Q2 2014.
- Dow Chemical Company's portfolio value fell 2.1% quarter-over-quarter to $1.19B.
Based on Dow Chemical Company's 13F filing for Q2 2014, filed 11 Aug 2014.